-
Kepler Cheuvreux Starts Smith & Nephew PLC. (SN:LN) (SNN) at Buy
-
Smith & Nephew PLC. (SN:LN) (SNN) PT Raised to GBP17 at RBC Capital
-
Bernstein SocGen Group Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Market Perform
-
Smith+Nephew announces study showing foam dressing absorbs 93% of mechanical energy
-
BofA sees upside risk on earnings/valuation in this UK stock
-
Smith & Nephew plc (SNN) Reports 1H EPS of $0.43
-
Organogenesis Holding (ORGO), Smith & Nephew (SNN) & Integra LifeSciences (IART) Also Fall on CMS Publication
-
Smith & Nephew (SNN) PT Raised to $28 at Canaccord Genuity
-
HSBC Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Hold
-
UBS Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Neutral
-
Off Wall Street closes short recommendation for Smith & Nephew (SNN)
-
Smith & Nephew (SNN) expiring January 30 calls active as share price up 4.3%.
-
Smith & Nephew (SNN) Quickly Climbs to High, Up 6.5%
-
Berenberg Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Hold
-
Smith & Nephew (SNN) PT Lowered to $27 at Canaccord Genuity
-
RBC Capital Reiterates Outperform Rating on Smith & Nephew PLC. (SN:LN) (SNN)
-
Smith & Nephew (SNN) PT Raised to $39 at BofA Securities
-
Smith & Nephew plc (SNN) Reports Q2 results
-
Smith & Nephew PLC. (SN:LN) (SNN) PT Raised to GBP14 at Jefferies
-
Deutsche Bank Starts Smith & Nephew PLC. (SN:LN) (SNN) at Buy
-
Berenberg Reiterates Buy Rating on Smith & Nephew PLC. (SN:LN) (SNN)
-
Smith+Nephew (SNN) announces 510(k) clearance of new CATALYSTEM Primary Hip System
-
Smith & Nephew (SNN) jumps as activist Cevian Capital discloses stake
-
Smith & Nephew (SNN) named as new short at Off Wall Street

